Simple Summary Patients with primary Sjogren's syndrome (pSS) are at risk of developing extranodal marginal zone lymphoma (ENMZL) of the mucosa-associated lymphoid tissue (MALT) in the parotid glands. The genetic mechanism underlying development of MALT lymphoma in the context of pSS is unknown. The aim of our study was to define the genomic landscape of pSS-associated MALT lymphoma. For 17 localized pSS-associated MALT lymphomas, we analyzed the presence of nonsynonymous mutations, copy number alterations (CNAs) and MALT1 translocations. pSS-associated MALT lymphomas were characterized by a low mutational load (median number of nonsynonymous somatic variants per case was 7, range 2-78) and a limited number of CNAs. Unlike the recurrent gen...
Important characteristics of Sjögren syndrome include a sensation of dry mouth, reduced saliva secre...
Objective Patients with primary Sjogren's syndrome (pSS) have an increased risk of developing non-Ho...
Objective. To retrospectively analyze the clinical course of patients with mucosa-associated lymphoi...
Patients with primary Sjogren’s syndrome (pSS) are at risk of developing extranodal marginal zone ly...
Patients with primary Sjogren's syndrome (pSS) are at risk of developing extranodal marginal zone ly...
Patients with primary Sjögren’s syndrome (pSS) are at increased risk of developing malignant lymphom...
A 44-year-old woman with a 12-year history of Sjögren's syndrome (SS) developed a low-grade mucosa-a...
Five percent of the cancers in the parotid region are non-hodgkin lymphomas. This lymphoma, involvin...
Objective. To identify key target genes and activated signaling pathways associated with the pathoge...
OBJECTIVE: To characterize Sj\uf6gren's syndrome (SS)-related B cell lymphoproliferation at the prem...
A major complication of primary Sjögren's syndrome (pSS) is development of mucosa associated lymphoi...
OBJECTIVE: Patients with Sjӧgren's syndrome (SS) have an increased risk of developing malignant B ce...
A major complication of primary Sjögren's syndrome (pSS) is development of mucosa associated lymphoi...
Aim. To develop algorithm of early diagnosis of extranodal lymphoma arising in patients with Sjorgen...
Sjogren's syndrome (SS) is an autoimmune disease characterised by lymphocyte mediated destruction of...
Important characteristics of Sjögren syndrome include a sensation of dry mouth, reduced saliva secre...
Objective Patients with primary Sjogren's syndrome (pSS) have an increased risk of developing non-Ho...
Objective. To retrospectively analyze the clinical course of patients with mucosa-associated lymphoi...
Patients with primary Sjogren’s syndrome (pSS) are at risk of developing extranodal marginal zone ly...
Patients with primary Sjogren's syndrome (pSS) are at risk of developing extranodal marginal zone ly...
Patients with primary Sjögren’s syndrome (pSS) are at increased risk of developing malignant lymphom...
A 44-year-old woman with a 12-year history of Sjögren's syndrome (SS) developed a low-grade mucosa-a...
Five percent of the cancers in the parotid region are non-hodgkin lymphomas. This lymphoma, involvin...
Objective. To identify key target genes and activated signaling pathways associated with the pathoge...
OBJECTIVE: To characterize Sj\uf6gren's syndrome (SS)-related B cell lymphoproliferation at the prem...
A major complication of primary Sjögren's syndrome (pSS) is development of mucosa associated lymphoi...
OBJECTIVE: Patients with Sjӧgren's syndrome (SS) have an increased risk of developing malignant B ce...
A major complication of primary Sjögren's syndrome (pSS) is development of mucosa associated lymphoi...
Aim. To develop algorithm of early diagnosis of extranodal lymphoma arising in patients with Sjorgen...
Sjogren's syndrome (SS) is an autoimmune disease characterised by lymphocyte mediated destruction of...
Important characteristics of Sjögren syndrome include a sensation of dry mouth, reduced saliva secre...
Objective Patients with primary Sjogren's syndrome (pSS) have an increased risk of developing non-Ho...
Objective. To retrospectively analyze the clinical course of patients with mucosa-associated lymphoi...